Skip to main content
. 2022 Mar 22;14(2):310–321. doi: 10.3390/neurolint14020025
AD Alzheimer’s disease
NMDA N-methyl-D-aspartate
SSRI selective serotonin reuptake inhibitor
mTOR Mammalian target of rapamycin
BDNF Brain-derived neurotrophic factor
GluA1 Glutamate A1
SI Suicidal Ideation
PTSD Post-traumatic stress disorder
ECT Electroconvulsive therapy
QUIN Quinolinic acid